In most human sporadic prion diseases the phenotype is consistently associated with specific pairings of the genotype at codon 129 of the prion protein gene and conformational properties of the scrapie PrP (PrP Sc ) grossly identified types 1 and 2. This association suggests that the 129 genotype favours the selection of a distinct strain that in turn determines the phenotype. However, this mechanism cannot play a role in the phenotype determination of sporadic fatal insomnia (sFI) and a subtype of sporadic Creutzfeldt-Jakob disease (sCJD) identified as sCJDMM2, which share 129 MM genotype and PrP Sc type 2 but are associated with quite distinct phenotypes. Our detailed comparative study of the PrP Sc conformers has revealed major differences between the two diseases, which preferentially involve the PrP Sc component that is sensitive to digestion with proteases (senPrP Sc ) and to a lesser extent the resistant component (resPrP Sc ). We conclude that these variations are consistent with two distinct strains in sFI and sCJDMM2, and that the rarer sFI is the result of a variant strain selection pathway that might be favoured by a different brain site of initial PrP Sc formation in the two diseases.
No takes yet. Share an insight, caveat, or question.
Cracco et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: